Amid financial and reputational turmoil, top executives at UnitedHealth Group have promised to bring more transparency. A new reporting policy from the health care giant is doing the opposite.
This week, UnitedHealth listed just 10 subsidiaries in its annual report, filed with the Securities and Exchange Commission. A year ago, the company disclosed nearly 3,100.
UnitedHealth is the country’s biggest health care conglomerate, and the far more limited disclosure hides the scope of its sprawling network of businesses that includes insurance, medical clinics, and pharmacies. This shift raises concerns among B2B professionals in the pharma sector, as reduced transparency could impact regulatory scrutiny and complicate sourcing and portfolio management. Stakeholders must now navigate an environment where critical insights into operational structure are obscured, potentially affecting partnerships and compliance strategies.
Start your 7-day trial and see what the database can do →
